Phospholipase_NN
C_NN
gamma_NN
1_CD
overexpression_NN
and_CC
activation_NN
induced_VBN
by_IN
interferon_NN
beta_NN
in_IN
human_JJ
T_NN
lymphocytes_NNS
:_:
an_DT
ISGF3-independent_JJ
response_NN
._.

Interferons_NNS
exert_VBP
their_PRP$
antiviral_JJ
,_,
antiproliferative_JJ
and_CC
immunoregulatory_JJ
activities_NNS
by_IN
stimulating_VBG
the_DT
expression_NN
of_IN
several_JJ
genes_NNS
._.

Such_JJ
genes_NNS
disclose_VBP
a_DT
common_JJ
element_NN
within_IN
their_PRP$
promoters_NNS
,_,
defined_VBN
Interferon_NN
Stimulated_NN
Response_NN
Element_NN
-LRB-_-LRB-
ISRE_NN
-RRB-_-RRB-
,_,
which_WDT
binds_VBZ
a_DT
nuclear_JJ
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
translocated_VBN
from_IN
the_DT
cytoplasm_NN
to_TO
the_DT
nucleus_NN
-LRB-_-LRB-
ISGF3_NN
-RRB-_-RRB-
after_IN
the_DT
binding_NN
of_IN
interferon_NN
-LRB-_-LRB-
IFN_NN
-RRB-_-RRB-
to_TO
the_DT
specific_JJ
receptor_NN
._.

Here_RB
we_PRP
report_VBP
the_DT
induction_NN
of_IN
the_DT
synthesis_NN
and_CC
of_IN
the_DT
hydrolytic_JJ
activity_NN
of_IN
phospholipase_NN
C_NN
gamma_NN
1_CD
-LRB-_-LRB-
PLC_NN
gamma_NN
1_CD
-RRB-_-RRB-
in_IN
human_JJ
T_NN
lymphocytes_NNS
by_IN
IFN-beta_NN
._.

The_DT
increased_VBN
level_NN
of_IN
PLC_NN
gamma_NN
1_CD
becomes_VBZ
evident_JJ
after_IN
90_CD
min_NN
of_IN
IFN-beta_NN
treatment_NN
and_CC
is_VBZ
still_RB
detectable_JJ
after_IN
24_CD
h_NN
._.

Neither_CC
the_DT
PLC_NN
gamma_NN
1_CD
overexpression_NN
induced_VBN
by_IN
IFN_NN
nor_CC
the_DT
increased_VBN
hydrolytic_JJ
activity_NN
of_IN
the_DT
enzyme_NN
appear_VBP
to_TO
be_VB
affected_VBN
by_IN
pretreatment_NN
of_IN
the_DT
cells_NNS
with_IN
the_DT
protein_NN
tyrosine_NN
kinase_NN
inhibitor_NN
genistein_NN
,_,
which_WDT
is_VBZ
known_VBN
to_TO
prevent_VB
the_DT
association_NN
of_IN
ISGF3_NN
components_NNS
._.

These_DT
results_NNS
suggest_VBP
that_IN
in_IN
human_JJ
T_NN
lymphocytes_NNS
IFN-beta_NN
can_MD
activate_VB
other_JJ
transcription_NN
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
distinct_JJ
from_IN
ISGF3_NN
to_TO
regulate_VB
PLC_NN
gamma_NN
1_CD
expression_NN
._.

In_IN
addition_NN
,_,
the_DT
ability_NN
of_IN
this_DT
enzyme_NN
to_TO
hydrolyse_VB
PIP2_NN
,_,
also_RB
in_IN
the_DT
presence_NN
of_IN
genistein_NN
,_,
implies_VBZ
the_DT
possibility_NN
that_IN
this_DT
enzyme_NN
can_MD
exert_VB
its_PRP$
hydrolytic_JJ
activity_NN
independently_RB
of_IN
protein_NN
tyrosine_NN
kinase_NN
activation_NN
._.

